no personally identifiable information is contained in the tiberius system. as for the size of the contract, palantir declined comment. government work is critical here in november in its first earnings report, it said sales to government agencies jumped nearly 70% to $163 million and that stock is on a roll, now up more than 250% from its public debut in september. back to you. >> so, josh, just to make sure i'm sort of following this, it's a government program that uses palantir technicology and its da mining what is the purpose of doing that by the way, palantir is a very controversial company sometimes for its political ties, its ties to the government. has that played a role in the way all of this is getting rolled out >> to the first part of your question, it provides software to customers and allows them to integrate all kind of huge volumes of data, where it can be analyzed and visualized. tiberius is using that software, sucking in all that data from the federal agencies you're looking at shipments, inventory of the vaccine, delivery, coverage and of

>> what we're doing is through tiberius, the program that we established which is located at each of the jurisdictions, we're establishing the available doses of vaccine to each state, and so they get to see that. the tiberius allows them to see the allocation, allows them to go through a planning process of where they would like to have the vaccine to go to manipulated so that they can see impact of the doses going to those locations, and then once finally approved, they hit send and that is how we distribute. so, quick answer to your question is through tiberius, open and transparent with each jurisdiction as allocations become available. and then the second part of your question, i apologize, i don't remember it. can anybody help me on that one? i can't remember. >> it was the allocation in the states, how do you allocate those to the states? >> i apologize. thank you. so the second part of the question was, are we going to hold the second dose for every distribution as we go forward in the cadence, and the answer is yes. our responsibility is to make sure that we have both doses

so, for example, a week and a half ago, around 20 november through tiberius, we identified we provided the 64 jurisdictions and five agencies the allocations for the pfizer vaccine of the four million doses that will be available. a week later on 27 november, we provided the 64 jurisdictions and five federal agencies, their allocations for the moderna vaccine at 12.5 million doses that will be available. . from the greatest distribution capability that they have. utilize the tiberias platform hat we developed which is a capability that takes in all the the mative data from doctors'ospitals, offices, pharmacies only on the specification of vaccine as it is delivered and vaccine as it is administered so that we can maintain the flow of vaccine to the american people. as i've talked about, our goal is to distribute within 24 hours after eua, and the first pushes, then we want to maintain a cadence, a deliberate, planned, coordinated cadence of delivery of vaccine as it becomes available. the only way you can do that is if you see yourselves, and we have to see ourselves from point of admi

we utilize a tiberius platform that we developed, right, which is a capability that takes in all the informative data from the states, hospitals, doctors' offices, pharmacies, only on the specification of vaccine as it is delivered and vaccine as it is administered so that we can maintain the flow of vaccine to the american people. as i've talked about, our goal is to distribute within 24 hours after eua. and the first push is, then we want to maintain a cadence, a deliberate, planned, coordinated cadence of delivery of vaccine as it becomes available. the only way you can do that is if you see yourselves. and we have to see ourselves from point of administration all the way back to point of fill finish. and in doing so, then we can coordinate, collaborate, plan together the distribution of vaccines down to the states. we have requested that the states lock in their microplans for final distribution of both vaccines. so for example, this week we've asked the states and total jurisdictions to have their microplans in tiberius by the end of the week or for december. this way we can ens

releasable dosages, there was a difference between the worksheet and what i approved to go into tiberius. calls came in immediately the second day as we were working through the process of the difference between forecast and actual allocation, and we worked with governors, their staffs. i briefed several. i made several phone calls myself to talk to governors, i had a great phone call with the governor of washington, governor inslee. i really appreciated his time that he allowed me to walk them , through the process, very grateful. i talked with senator reed on the hill and walked him through the process. there was many other phone calls made by the staff out to many teams to help facilitate this conversation. at the end of the day, again, i accept responsibility for the miscommunication. we are learning. our strategy was to push the first major pushes from pfizer and moderna,a -- stocks that we had stacked up and were ready to go. the initial push after eua, relatively easy. we had very good plans that had been worked through through the states all the way through ows, cdc, down to our

this evening that states that really the confusion came from a new federal software system called tiberius written by the big data company loaded with essentially the wrong data that led states to believe they were getting more vaccine than they truly were. so this might all just be a big confusion. we have the vaccine. it'll probably be sorted out in the next several days. >> dr. schaffner, i want to talk about -- there is a new study that finds regeneron's antibody cocktail reduces a patient's viral load and works best in patients whose immune response hadn't kicked in yet. this is what president trump got. is this encouraging? >> well, we're going to be using this drug much more widely in the future. it is already being used fairly frequently. if we could prevent the development of serious disease among people who are infected, if we could intervene early enough so that the disease does not get into its later phases, the ones that require hospitalization, that would be terrific. and those, we're using that drug in our medical center now for just that purpose. >> dr. reiner, we have turn

they got the boxes, temperature controlled and a program called tiberius that will monitor that temperature control. all of this is the flesh on the bones that makes america listening and watching this re-assured that it is actually going to deliver millions of doses in a safe and effective why. >> bill: it's amazing stuff here. they're taking a break inside the room right now. when they continue and resume there, we'll take our viewers back inside. you're about halfway through the program. so doctor, when you were watching them show us how the, bos were made, the companies had to work with the doctors to make sure it was safe to travel, correct? >> that's right. you know what? i wish, bill, we could go back and replay the tapes of all the naysayers back in march, april, may who said repeatedly that it would take a year a couple years. meanwhile, marc siegel and myself were saying don't underestimate the power of the american scientific community. add mir -- admiral girard, very impressive. we got it done. a day everybody should be proud of. >> dr. marc siegel, we've had this back and forth

the allocation is what general perna puts into the tiberius system tuesday night.since monday when wide the number from advertise pfizer we said you'll get 2 million so that 2.9 number or any other number is not a basis for expectation for our governors. it's only what general perna does. when he snaps the line based on what pfizer tells us they've got vaccinated. >> will we see 50 million people vaccinated by the end of january? >> we will have 20 million doses available for vaccination during this month. and great news, george, just like last friday when i told you about pfizer, this morning i can tell you and your viewers that the fda has communicated to moderna that we expect to grant their emergency use authorization. that could come as soon as today. so more good friday vaccine news. in fact, i think maybe we should set up a regular date for you and me to talk every friday morning. >> until we don't have to do it anymore. you're right about that. if that happens today, if the fda makes that approval today, will the shipments start on sunday and the administra